Here are four things to know:
1. McKesson President and COO Brian Tyler, PhD, will succeed Mr. Hammergren as CEO, effective April 1, 2019. Dr. Tyler will continue to serve as president.
2. Edward Mueller, who currently serves as lead independent director of McKesson’s board of directors, will succeed Mr. Hammergren as an independent board chairman, effective April 1, 2019.
3. Since Mr. Hammergren became CEO in 2001, McKesson more than quadrupled revenues to $208 billion, expanded into global markets and advanced to number six on the Fortune 500.
4. Harvard Business Review named Mr. Hammergren as one of 100 “Top Performing CEOs in the World.”
More articles on devices:
Moving forward with motion preservation in spine: Key trends from Simplify Medical CEO David Hovda
DJO launches 1st outpatient arthroplasty risk assessment tool: 4 things to know
Paralyzed patients walk again in epidural implant study — 5 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
